-
EP3777892
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3777892
| EP3777892 - PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRAN ETEXILATE AND PREPARATION METHOD THEREOF [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 27.06.2024 Database last updated on 14.11.2024 | |
| Former | Request for examination was made Status updated on 15.01.2021 | ||
| Former | The international publication has been made Status updated on 12.10.2019 | Most recent event Tooltip | 14.10.2024 | Change: Despatch of examination report + time limit | Applicant(s) | For all designated states Shanghai WD Pharmaceutical Co., Ltd Room 403, Building 1, Lane 720 Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | [2021/07] | Inventor(s) | 01 /
DONG, Liang Chang Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | 02 /
ZHANG, Shizhong Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | 03 /
JIAO, Yan Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | 04 /
ZHANG, Danyong Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | 05 /
ZHAO, Wenfang Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | 06 /
SHI, Jingmin Room 403, Building 1, Lane 720, Cailun Road Zhangjiang High-Tech Park, Pudong New Area Shanghai 201203 / CN | [2021/07] | Representative(s) | Grünecker Patent- und Rechtsanwälte PartG mbB Leopoldstraße 4 80802 München / DE | [2021/07] | Application number, filing date | 18913737.5 | 27.11.2018 | [2021/07] | WO2018CN117619 | Priority number, date | CN201810300259 | 04.04.2018 Original published format: CN201810300259 | [2021/07] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019192195 | Date: | 10.10.2019 | Language: | ZH | [2019/41] | Type: | A1 Application with search report | No.: | EP3777892 | Date: | 17.02.2021 | Language: | EN | [2021/07] | Search report(s) | International search report - published on: | CN | 10.10.2019 | (Supplementary) European search report - dispatched on: | EP | 30.04.2021 | Classification | IPC: | A61K9/16, A61K9/48, A61K9/50, A61K31/4439, A61P7/02, A61P9/10, A61P9/14, A61P11/00 | [2021/22] | CPC: |
A61K9/5078 (EP,CN);
A61K9/146 (CN);
A61K31/4439 (EP,CN,US);
A61K47/10 (US);
A61K47/12 (US);
A61K47/26 (US);
A61K47/32 (US);
A61K47/34 (CN);
A61K47/38 (US);
A61K9/1641 (EP,CN);
A61K9/1676 (EP);
A61K9/1694 (US);
A61K9/4866 (EP);
A61K9/5031 (EP,CN);
A61P11/00 (EP,CN);
|
| Former IPC [2021/07] | A61K47/34, A61K31/4439, A61P7/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/07] | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT DABIGATRAN ETEXILAT UND VERFAHREN ZU IHRER HERSTELLUNG | [2021/07] | English: | PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRAN ETEXILATE AND PREPARATION METHOD THEREOF | [2021/07] | French: | COMPOSITION PHARMACEUTIQUE CONTENANT DU DABIGATRAN ÉTEXILATE ET SON PROCÉDÉ DE PRÉPARATION | [2021/07] | Entry into regional phase | 02.11.2020 | Translation filed | 02.11.2020 | National basic fee paid | 02.11.2020 | Search fee paid | 02.11.2020 | Designation fee(s) paid | 02.11.2020 | Examination fee paid | Examination procedure | 02.11.2020 | Examination requested [2021/07] | 29.11.2021 | Amendment by applicant (claims and/or description) | 28.06.2024 | Despatch of a communication from the examining division (Time limit: M06) | Fees paid | Renewal fee | 02.11.2020 | Renewal fee patent year 03 | 25.11.2021 | Renewal fee patent year 04 | 23.11.2022 | Renewal fee patent year 05 | 28.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2015071841 (DRUGGABILITY TECHNOLOGIES HOLDINGS LTD [IE]); |